Luminescent pentafluorophenyl-cycloplatinated complexes: synthesis, characterization, photophysics, cytotoxicity and cellular imaging.

Luminescent mono(pentafluorophenyl) cycloplatinated complexes [Pt(C^N-κC,N)(HC^N-κN)(C6F5)] [HC^N = Hthpy (2-(2-thienyl)pyridine) 2a, Hbt (2-phenylbenzothiazole) 2b, Hpq (2-phenylquinoline) 2c] have been prepared by C­H activation of a HC^N ligand in the corresponding [Pt(HC^N-κN)2(C6F5)2] (1a, 1b, 1c) complexes. Complexes 2 evolve in DMSO solution into solvate complexes and we present here successful routes for the synthesis of [Pt(C^N)(C6F5)(DMSO)] (C^N = thpy 3a, bt 3b). They have been fully characterized (X-ray for 1a, 1c, 2b, 3a and 3b), their electronic absorption and emission properties have been investigated and DFT and TD-DFT calculations for 1a, 1c, 2b and 3a have been carried out. Complexes 3a, 3b and [Pt(ppy)(C6F5)(DMSO)] 4 (Hppy = 2-phenylpyridine) show remarkable stability in a mixed DMSO-cellular medium and their cytotoxicity towards the human lung tumor (A549) and bronchial epithelial non-tumorigenic (NL20) cell lines has been evaluated by MTS assays. Their cellular localization in A549 and NL20 human cells and in mouse embryonic fibroblasts obtained from lungs (LMEFs) has also been investigated by fluorescence microscopy.

Luminescent alkynyl platinum-cadmium complexes: structural characterization of an unusual decanuclear cluster.

The reaction of (NBu(4))(2)[Pt(C triple bond CPh)(4)] with Cd(ClO(4))(2).6H(2)O in a 1:1 molar ratio yields a white solid [PtCd(C triple bond CPh)(4)](n) 1 (75% yield) together with yellow crystals of a very unusual decanuclear platinum-cadmium cluster [Pt(4)Cd(6)(C triple bond CPh)(4)(mu-C triple bond CPh)(12)(mu(3)-OH)(4)] 2 in low yield. Slow diffusion of acetonic solutions of the starting materials under aerobic conditions only produces crystals of 2 which have been shown by an X-ray analysis to be composed of a big hexanuclear cation [Cd(6)(mu(3)-OH)(4)](8+) and four [Pt(C triple bond CPh)(4)](2-) anions, held together by Pt.Cd and pi.Cd acetylide interactions. On the other hand, treatment of the insoluble product 1 with 1 equiv of NBu(4)X yields tetranuclear mixed-metal soluble complexes (NBu(4))(2)[[Pt(mu-C triple bond CPh)(4)](2)(CdX)(2)] (X = Cl A, Br 3, CN 4), which contain two platinate fragments connected by two CdX units through Pt.Cd and mainly Cd.C(alpha) interactions. All complexes are strongly emissive in the solid state at room temperature.

Tratamiento quirúrgico del melanoma / Surgical treatment of melanoma

Este trabajo de revisión sólo pretende dar una visión actual y práctica del tratamiento quirúrgico del melanoma tras haber efectuado una búsqueda de los datos más relevantes publicados en este aspecto. En sus conclusiones se puede deducir que esencialmente el tratamiento quirúrgico parece ser el único que tiene una efectividad aceptable en esta enfermedad, no obstante desde hace unos años se ha verificado que la efectividad no está en relación con la extensión de la cirugía una vez que se cumplen unos márgenes mínimos. Del mismo modo en cuanto o las técnicas de reconstrucción éstas deben emplearse en función de la zona a tratar, sus necesidades y de la disponibilidad de técnicas, eligiendo la más adecuada al defecto. Otro aspecto discutido es la utilidad de la linfadenectomía electiva y como contrapunto la posibilidad de obviarla en función de la detección precoz de micrometástasis y la biopsia del ganglio centinela. En esencia la diferenciación de grupos de bajo y alto riesgo de recidiva o metástasis a distancia tiene repercusiones importantes en la elaboración del pronóstico y la utilización de otras terapéuticas (interferon) como tratamiento adyuvante en los grupos que pudieran beneficiarse. Finalmente se discute la realización de técnicas quirúrgicas en metástasis a distancia (AU)

Double Insertion of Coordinated Phosphanylalkyne Ligands into a Pt-C(6)F(5) Bond.

Enhanced reactivity is shown by uncoordinated C identical withC bonds in the proximity of a metal in phosphanylacetylene complexes. cis-[Pt(C(6)F(5))(2)(thf)(2)] reacts with [M(C(6)F(5))(2)(PPh(2)C identical withCPh)(2)] (M=Pt, Pd) to form binuclear complexes containing the novel 2,3-bis(diphenylphosphanyl)-1,3-butadien-1-yl bridging ligand. Substitution of the solvent ligands with, for example, PPh(2)H (see picture) provides species that could be characterized by X-ray crystallography.

Effect of L-ornithine 8-vasopressin on blood loss during liposuction.

In this comparative study, we carried out liposuction on 20 patients randomly divided in two groups to find an alternative medication to epinephrine that would not result in secondary effects at the cardiovascular level but would offer a similar vasoconstricting capacity. Also, a variation of the wet technique is described that decreases blood loss secondary to liposuction. The area to undergo liposuction is infiltrated with a cannula of our own design. Epinephrine is not used as a vasoconstrictor but rather L-ornithine 8-vasopressin at a concentration of 0.01 IU/ml chilled saline. With this new technique, the amount of blood removed is minimal, even in the case of extraction of large volumes of fat.

The use of latissimus dorsi muscle flap in reconstructive heart surgery.

Dynamic cardiomyoplasty is a technique for ventricular assistance indicated for the correction of left ventricle aneurysm and for cardiomyopathies in which heart transplantation is contraindicated. In this article, our first four patients to undergo cardiomyoplasty (from February 1991 until April 1992) with a left latissimus dorsi island flap, rotated into the thorax after a 3-week training period, are reviewed. Therapeutic indications were cardiomyopathy with contraindication for heart transplant in patients 1 and 4 and associated to surgery for left ventricle aneurysm for patients 2 and 3. Patient 1 died 4 months after surgery because of a cerebral embolism when he was at functional class II. The other three patients remain at functional class I, carrying out normal activities. All the data were evaluated with the paired t test. Ejection fraction values (obtained through echocardiography and scintigraphy studies) and maximum minute flow rate of blood (measured with an echo-Doppler) have increased significantly (p < 0.001, p < 0.05, and p < 0.01, respectively) after heart surgery. Clinical improvement has been found after cardiomyoplasty, which correlates with an increase in ejection fraction and maximum minute flow rate of blood.